Common Mistakes
    FDA Safety

    Semaglutide Dosing Errors: FDA Warnings and How to Measure Correctly

    Understanding the FDA's concerns about dosing confusion and how to accurately measure every injection.

    Last updated: March 25, 2026·15 min read

    Quick answer

    If you accidentally double-dosed your GLP-1 (semaglutide or tirzepatide), do not take a correction dose. Contact your prescriber right away, watch for intensified nausea, vomiting, or low blood sugar, stay hydrated, and skip your next scheduled dose only if your provider advises it. Seek urgent care for severe symptoms. Individual outcomes vary.

    FDA Safety Alert

    The FDA has received reports of dosing errors with compounded semaglutide products, some resulting in hospitalizations. The primary issue is confusion between milligrams (the dose) and units (the volume marking on syringes). This article explains how to measure correctly and avoid these errors.

    The surge in popularity of semaglutide for weight loss has brought with it a concerning wave of dosing errors, particularly with compounded formulations. The FDA has issued multiple communications warning patients and providers about the risk of medication errors when drawing semaglutide from multi-dose vials. Understanding the math behind dosing is critical for your safety. This article is general information, not medical advice, and is not a substitute for guidance from a licensed clinician.

    What the FDA Is Worried About

    The FDA's concerns center on several interconnected issues with compounded semaglutide:

    1. Concentration Variability

    Unlike brand-name Ozempic and Wegovy, which come in pre-filled pens with fixed concentrations set out in their FDA-approved labeling, compounded semaglutide vials come in many different concentrations. One pharmacy may compound at 1 mg/mL, another at 2.5 mg/mL, and another at 5 mg/mL. A patient switching pharmacies or refilling from a different source may not realize the concentration changed, leading to a 2-5x dosing error.

    2. Unit vs. Milligram Confusion

    Insulin syringes are marked in "units," where 100 units = 1 mL. Semaglutide is prescribed in milligrams. The conversion between units (volume) and milligrams (drug amount) depends entirely on the concentration of the solution. This two-step calculation confuses many patients and even some healthcare providers.

    3. Syringe Reading Errors

    Insulin syringes come in different sizes (0.3 mL, 0.5 mL, 1 mL) with different marking increments. Reading small volumes on these syringes requires careful attention. A patient who misreads 5 units as 50 units would receive 10 times the intended dose.

    4. Prescribing Inconsistencies

    Some prescriptions specify the dose in milligrams, others in units, and others in milliliters. When the prescription format does not match the syringe markings, patients must perform conversions that introduce error opportunities.

    Understanding Concentration: The Key to Correct Dosing

    The concentration of your semaglutide vial is the single most important number to know. It tells you how much active semaglutide is in each milliliter of solution.

    Common Compounded Semaglutide Concentrations

    ConcentrationVolume for 0.25 mgVolume for 0.5 mgVolume for 1.0 mgVolume for 2.5 mg
    1 mg/mL0.25 mL (25 units)0.50 mL (50 units)1.00 mL (100 units)2.50 mL (N/A*)
    2.5 mg/mL0.10 mL (10 units)0.20 mL (20 units)0.40 mL (40 units)1.00 mL (100 units)
    5 mg/mL0.05 mL (5 units)0.10 mL (10 units)0.20 mL (20 units)0.50 mL (50 units)
    10 mg/mL0.025 mL (2.5 units)0.05 mL (5 units)0.10 mL (10 units)0.25 mL (25 units)

    *Exceeds standard 1 mL syringe capacity. Not a practical volume for a single injection.

    The Dose Calculation Formula

    How to Calculate Your Injection Volume

    Volume (mL) = Prescribed Dose (mg) / Concentration (mg/mL)

    Example:

    Prescribed dose: 0.5 mg | Vial concentration: 2.5 mg/mL

    0.5 mg / 2.5 mg/mL = 0.20 mL = 20 units on an insulin syringe

    Converting mL to Units:

    On a standard 100-unit insulin syringe: 1 mL = 100 units

    So multiply your mL result by 100 to get units

    0.20 mL x 100 = 20 units

    Step-by-Step: Measuring Your Dose Safely

    1. Verify your vial concentration. Read the label carefully. Find the mg/mL value. If you are unsure, call your pharmacy before injecting.
    2. Confirm your prescribed dose. Check your prescription or provider's instructions. Know the exact milligram amount you should be taking.
    3. Do the math. Divide your dose by the concentration to get the volume in mL. Multiply by 100 to convert to units if using an insulin syringe.
    4. Double-check. Many pharmacies include a dosing chart or instruction card with the vial. Compare your calculation to their chart.
    5. Use the right syringe. For small volumes (under 0.3 mL), use a 0.3 mL (30-unit) insulin syringe for better precision. For larger volumes, use a 0.5 mL or 1.0 mL syringe.
    6. Draw carefully. Hold the syringe at eye level. Align the top of the plunger (the flat edge closest to the needle) with the correct marking.
    7. Verify before injecting. Confirm the volume in the syringe matches your calculation before proceeding with the injection.

    Real-World Dosing Errors Reported to the FDA

    Reported Error Patterns:

    • 5x overdose: Patient switched from 1 mg/mL to 5 mg/mL concentration without adjusting volume. Drew the same number of units, receiving 5 times the intended dose.
    • 10x overdose: Patient confused "units" on the syringe with "milligrams" of semaglutide. Drew 50 units thinking it was 0.5 mg, but at 5 mg/mL, it was actually 2.5 mg.
    • Wrong syringe: Patient used a tuberculin syringe marked in mL instead of an insulin syringe marked in units, leading to volume confusion.
    • Misread markings: Patient with a 0.3 mL syringe misread the small hash marks and drew 0.25 mL instead of 0.025 mL, a 10x error.

    Safety Tips to Prevent Dosing Errors

    Dosing Safety Checklist

    • Write it down. Keep a card next to your vial with your prescribed dose, concentration, and calculated volume. Review it before every injection.
    • Ask for a dosing chart. Request that your pharmacy provide a specific dosing chart for your concentration when you fill your prescription.
    • Verify new vials. Every time you open a new vial, verify the concentration on the label matches what you expect. If it changed, recalculate your volume.
    • Use consistent syringe sizes. Stick with one syringe type and size so you become familiar with its markings.
    • Good lighting. Draw your dose in a well-lit area where you can clearly see the syringe markings.
    • Reading glasses if needed. Syringe markings are small. Use magnification if you have any difficulty reading them.
    • Have someone check. Especially for the first few injections, have a family member or partner verify your syringe volume against your calculated dose.

    Why Pre-Filled Pens Eliminate These Risks

    Brand-name semaglutide pens (Ozempic, Wegovy) virtually eliminate dosing errors because:

    • The dose selector clicks to preset mg amounts
    • No concentration math is required
    • No syringe reading is needed
    • The pen delivers a fixed volume for each dose setting
    • Dose confirmation windows show the selected dose

    The dosing schedule itself, the gradual titration studied in the NEJM STEP 1 trial, is the same regardless of whether the active ingredient comes from a pen or a compounded vial. The trade-off is cost. Compounded semaglutide is significantly less expensive, but requires patient education about proper dosing technique. If the math and measuring create anxiety, discuss this with your provider. The confidence that comes from an accurate dose is important for treatment adherence.

    What Your Provider Should Do

    Good prescribers of compounded semaglutide should:

    • Specify the dose in milligrams AND the volume in mL or units on the prescription
    • Include the concentration in their instructions
    • Provide a dosing chart or calculator specific to your concentration
    • Demonstrate proper syringe technique or provide instructional videos
    • Follow up early in treatment to verify you are measuring correctly
    • Ask about dosing confidence at each check-in

    Key Takeaways

    • Dosing errors with compounded semaglutide are a documented FDA concern
    • The main risk is confusing units (volume) with milligrams (drug amount)
    • Always know your vial's concentration before calculating your dose
    • Use the formula: Volume = Dose / Concentration
    • Keep a written dosing reference next to your medication
    • Verify the concentration on every new vial
    • When in doubt, call your pharmacy before injecting

    Medical Disclaimer: This article is general information for educational purposes only and is not a substitute for advice from a licensed clinician. Always follow your prescriber's specific dosing instructions and never adjust a dose without provider guidance. If you are unsure about your dose calculation, contact your pharmacy or healthcare provider before injecting.

    Clear Dosing Instructions with Every Prescription

    Trimi Health provides personalized dosing charts, video instructions, and medical team access with every prescription.

    Get Started Today

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What are common semaglutide dosing errors?

    FDA has issued warnings about semaglutide dosing errors particularly affecting compounded medications. Per FDA semaglutide dosing-error notice (2024) and ongoing pharmacovigilance, common errors include: (1) Unit confusion, semaglutide doses are often expressed in mg (e.g., 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg for weekly dosing) but compounded vials may use mcg or different concentration units; patients have accidentally taken 10× or 100× intended doses due to unit misunderstanding. (2) Needle misuse, incorrect needle attachment to pens, drawing the medication into the syringe at wrong volume from vials, intramuscular vs subcutaneous injection. (3) Volume errors with vials, drawing too much or too little when measuring from a multi-dose vial (compounded medications often come in vials rather than pre-filled pens). (4) Inconsistent injection schedule, missing doses, taking double doses to compensate, irregular weekly intervals. Per FDA Wegovy and Ozempic prescribing information: standardized weekly schedule with clear titration steps from 0.25 mg/week to 2.4 mg/week; follow exact dosing instructions provided by prescribing clinician. Risk reduction strategies: use prefilled pens when possible (less error-prone than vials); confirm dose with prescribing clinician at each titration step; track injections in a tracking app or paper log; double-check dose calculation if using vials (multiply unit dose × concentration to get volume to draw); have a family member or partner verify dose in early titration weeks. If overdose suspected: contact prescribing clinician or poison control (1-800-222-1222 in US) immediately; do NOT take additional doses or attempt to compensate. Symptoms of overdose: severe nausea/vomiting, severe hypoglycemia (especially if combined with insulin), dehydration, acute kidney injury risk. Trimi Health's 503A pharmacy partners (VialsRx, GreenwichRx) provide clear labeling on compounded products; prescribing clinicians via Arora Health 50-state network review dosing at each titration step.

    Common errors: unit confusion, needle misuse, vial volume errors.
    Reduce risk: prefilled pens when possible; track injections; verify with clinician.
    Suspected overdose: poison control 1-800-222-1222 US.

    Key Takeaways

    • FDA has issued warnings about semaglutide dosing errors due to compounded medication mislabeling, dosing pen misuse, and patient confusion.
    • Common errors: confusing units (mcg vs mg), wrong needle insertion, drawing too much or too little from vials, inconsistent injection schedule.
    • Per FDA prescribing information for Wegovy/Ozempic: standardized weekly schedule with clear titration steps; follow exact dosing instructions.
    • Risk reduction: use prefilled pens when possible (less error than vials); confirm dose with prescribing clinician at each titration step; track injections in app.
    • If overdose suspected: contact prescribing clinician or poison control (1-800-222-1222 US) immediately; do NOT take additional doses.

    Medically Reviewed

    DSA

    Dr. Sean Arora

    MD

    Weight Loss Medicine, Obesity Medicine & Telemedicine

    Last reviewed: October 2, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Dr. Sean Arora, MD

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    - Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    - Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. U.S. Food and Drug Administration (2024). FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. FDA.Read Study
    2. Novo Nordisk (2025). Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.Read Study
    3. Novo Nordisk (2025). Ozempic (semaglutide) prescribing information. U.S. Food and Drug Administration.Read Study
    4. U.S. Food and Drug Administration (2025). FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Buy compounded semaglutide online in Texas for $99/month. Learn about Texas telehealth laws, compounding pharmacy access, and how to start affordable GLP-1 weight loss treatment.

    The most comprehensive 2026 guide to tirzepatide (Mounjaro/Zepbound) for weight loss. Covers dual GIP/GLP-1 mechanism, SURMOUNT trial data, dosing, side effects, cost comparison, and compounded tirzep

    Buy compounded semaglutide online in Florida for $99/month. Florida telehealth access, compounding pharmacy regulations, and affordable GLP-1 weight loss treatment.

    Buy compounded semaglutide online in Illinois for $99/month. Chicago and statewide telehealth access to affordable GLP-1 weight loss treatment.

    Start your GLP-1 journey, from $99/mo

    Get Started